BioCentury
ARTICLE | Company News

Amedis, Paradigm Thera deal

January 17, 2005 8:00 AM UTC

Paradigm acquired Amedis for an undisclosed amount of stock. The deal combines Amedis' medicinal and silicon chemistry capabilities with Paradigm's targets and in vivo genomics technology. Amedis also...